These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7978789)

  • 1. Modulation of bone resorption by tetracyclines.
    Rifkin BR; Vernillo AT; Golub LM; Ramamurthy NS
    Ann N Y Acad Sci; 1994 Sep; 732():165-80. PubMed ID: 7978789
    [No Abstract]   [Full Text] [Related]  

  • 2. Cathepsin B and L activities in isolated osteoclasts.
    Rifkin BR; Vernillo AT; Kleckner AP; Auszmann JM; Rosenberg LR; Zimmerman M
    Biochem Biophys Res Commun; 1991 Aug; 179(1):63-9. PubMed ID: 1883385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and regulation of bone resorption by osteoclasts.
    Katunuma N
    Curr Top Cell Regul; 1997; 35():179-92. PubMed ID: 9192181
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin-stimulated bone resorption by chick osteoclasts.
    Chowdhury MH; Moak SA; Rifkin BR; Greenwald RA
    Agents Actions; 1993 Sep; 40(1-2):124-8. PubMed ID: 8147268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of cathepsin L on bone resorption.
    Kakegawa H; Nikawa T; Tagami K; Kamioka H; Sumitani K; Kawata T; Drobnic-Kosorok M; Lenarcic B; Turk V; Katunuma N
    FEBS Lett; 1993 Apr; 321(2-3):247-50. PubMed ID: 8477857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.
    Sato T; Foged NT; Delaissé JM
    J Bone Miner Res; 1998 Jan; 13(1):59-66. PubMed ID: 9443791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tetracyclines on bone metabolism.
    Vernillo AT; Rifkin BR
    Adv Dent Res; 1998 Nov; 12(2):56-62. PubMed ID: 9972123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical study of cathepsin L and rat salivary cystatin-3 in rat osteoclasts treated with E-64 in vivo.
    Moroi R; Yamaza T; Nishiura T; Nishimura Y; Terada Y; Abe K; Himeno M; Tanaka T
    Arch Oral Biol; 1997 Apr; 42(4):305-15. PubMed ID: 9222450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone.
    Everts V; Korper W; Jansen DC; Steinfort J; Lammerse I; Heera S; Docherty AJ; Beertsen W
    FASEB J; 1999 Jul; 13(10):1219-30. PubMed ID: 10385612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin K is the principal protease in giant cell tumor of bone.
    Lindeman JH; Hanemaaijer R; Mulder A; Dijkstra PD; Szuhai K; Bromme D; Verheijen JH; Hogendoorn PC
    Am J Pathol; 2004 Aug; 165(2):593-600. PubMed ID: 15277232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone.
    Everts V; Delaissé JM; Korper W; Beertsen W
    J Bone Miner Res; 1998 Sep; 13(9):1420-30. PubMed ID: 9738514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein restriction influences glomerular matrix turnover and tubular hypertrophy by modulation of renal proteinase activities.
    Schaefer L; Meier K; Häfner C; Teschner M; Heidland A; Schaefer RM
    Miner Electrolyte Metab; 1996; 22(1-3):162-7. PubMed ID: 8676812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
    Kawamata H; Nakashiro K; Uchida D; Harada K; Yoshida H; Sato M
    Int J Cancer; 1997 Jan; 70(1):120-7. PubMed ID: 8985100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin K, osteoclastic resorption, and osteoporosis therapy.
    Zaidi M; Troen B; Moonga BS; Abe E
    J Bone Miner Res; 2001 Oct; 16(10):1747-9. PubMed ID: 11585336
    [No Abstract]   [Full Text] [Related]  

  • 16. Cathepsins in the osteoclast.
    Goto T; Yamaza T; Tanaka T
    J Electron Microsc (Tokyo); 2003; 52(6):551-8. PubMed ID: 14756243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine-proteinase localization in osteoclasts: an immunocytochemical study.
    Sasaki T; Ueno-Matsuda E
    Cell Tissue Res; 1993 Jan; 271(1):177-9. PubMed ID: 8443832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase inhibitors block osteoclastic resorption of calvarial bone but not the resorption of long bone.
    Everts V; Korper W; Docherty AJ; Beertsen W
    Ann N Y Acad Sci; 1999 Jun; 878():603-6. PubMed ID: 10415785
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterizing human colorectal carcinomas by proteolytic profile.
    Murnane MJ; Shuja S; Del Re E; Cai J; Iacobuzio-Donahue C; Klepeis V
    In Vivo; 1997; 11(3):209-16. PubMed ID: 9239513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.
    Sorsa T; Ramamurthy NS; Vernillo AT; Zhang X; Konttinen YT; Rifkin BR; Golub LM
    J Rheumatol; 1998 May; 25(5):975-82. PubMed ID: 9598901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.